Getein Biotech Inc. (stock code: 603387), established in 2002, is a fully integrated in vitro diagnostic company that researches and develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits in point-of-care testing (POCT), clinical chemistry, chemiluminescent assays, hematology, coagulation, urinalysis and molecular diagnostics. The company sits on a 10.5 square kilometers science park and is equipped with state-of-the-art R&D and production facilities. We also manufacture analytic medical devices and a variety of biological and non-biological raw materials for applications in diagnostics.
The SARS-CoV-2 Antigen Self-Test Test is intended for the qualitative detection of SARS-CoV-2 antigens in human nasal swab samples.
The SARS-CoV-2 antigen rapid test is intended for the qualitative detection of SARS-CoV-2 antigens in human saliva samples. The antigen rapid test kit is for Self-Test.
Subscribe to our weekly newsletter and receive exclusive offers on products you love!
X
